{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["L-arginine/NO pathway", "benzodiazepine/GABAergic receptors", "neurobehavioral effects", "neuromolecular mechanisms", "nitric oxide", "\u03b2-caryophyllene"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32386503", "DateCompleted": {"Year": "2021", "Month": "12", "Day": "21"}, "DateRevised": {"Year": "2021", "Month": "12", "Day": "21"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.2174/1874467213666200510004622"], "Journal": {"ISSN": "1874-4702", "JournalIssue": {"Volume": "14", "Issue": "1", "PubDate": {"Year": "2021"}}, "Title": "Current molecular pharmacology", "ISOAbbreviation": "Curr Mol Pharmacol"}, "ArticleTitle": "Anticonvulsant, Anxiolytic and Antidepressant Properties of the \u03b2-caryophyllene in Swiss Mice: Involvement of Benzodiazepine-GABAAergic, Serotonergic and Nitrergic Systems.", "Pagination": {"StartPage": "36", "EndPage": "51", "MedlinePgn": "36-51"}, "Abstract": {"AbstractText": ["Central nervous system disorders such as anxiety, depression and epilepsy are characterized by sharing several molecular mechanisms in common and the involvement of the L-arginine/NO pathway in neurobehavioral studies with \u03b2-caryophyllene is still little discussed.", "One of the objectives of the present study was to demonstrate the anxiolytic behavioral effect of \u03b2-caryophyllene (\u03b2-CBP) in female Swiss mice, as well as to investigate the molecular mechanisms underlying the results obtained.", "This study evaluated the neurobehavioral effects of \u03b2-CBP using the open field test, rota- rod test, elevated plus maze test, novelty suppressed feeding test, tail suspension test and forced swim test, as well as pilocarpine, pentylenetetrazole and isoniazid-induced epileptic seizure models.", "The results demonstrated that the neuropharmacological activities of \u03b2-CBP may involve benzodiazepine/GABAergic receptors, since the pre-treatment of \u03b2-CBP (200 mg/kg) associated with flumazenil (5 mg/kg, benzodiazepine receptor antagonist) and bicuculline (1 mg/kg, selective GABAA receptor antagonist) reestablished the anxiety parameters in the elevated plus-maze test, as well as the results of reduced latency to consume food in the novelty suppressed feeding test. In addition to benzodiazepine/GABAergic receptors, the neuropharmacological properties of \u03b2-CBP may be related to inhibition of nitric oxide synthesis, since pre-treatment with L-arginine (500-750 mg/kg) reversed significantly the anxiolytic, antidepressant and anticonvulsant activities of \u03b2-CBP.", "The results obtained provide additional support in understanding the neuromolecular mechanisms underlying the anxiolytic, antidepressant and anticonvulsive properties of \u03b2-CBP in female Swiss mice."], "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Federal Institute of Mato Grosso, Guaranta do Norte - MT, 78520-000, Guaranta do Norte Campus, Brazil."}], "LastName": "da Silva Oliveira", "ForeName": "George L", "Initials": "GL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Computer Science, Federal University of Piaui, Teresina, 64049-550, Piaui, Brazil."}], "LastName": "da Silva", "ForeName": "Jos\u00e9 C Correia L", "Initials": "JCCL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Federal University of Piaui, 64049-550, Teresina, Brazil."}], "LastName": "Dos Santos C L da Silva", "ForeName": "Ana P", "Initials": "AP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University Federal of Piaui, 64049-550, Teresina, Brazil."}], "LastName": "Feitosa", "ForeName": "Chistiane M", "Initials": "CM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Research on Medicinal Plants, Federal University of Piaui, 64049-550 Teresina, Brazil."}], "LastName": "de Castro Almeida", "ForeName": "Fernanda R", "Initials": "FR"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United Arab Emirates", "MedlineTA": "Curr Mol Pharmacol", "NlmUniqueID": "101467997", "ISSNLinking": "1874-4672"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Anxiety Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Anticonvulsants"}, {"RegistryNumber": "0", "NameOfSubstance": "Antidepressive Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "GABA-A Receptor Antagonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Polycyclic Sesquiterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, GABA-A"}, {"RegistryNumber": "12794-10-4", "NameOfSubstance": "Benzodiazepines"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "40P7XK9392", "NameOfSubstance": "Flumazenil"}, {"RegistryNumber": "94ZLA3W45F", "NameOfSubstance": "Arginine"}, {"RegistryNumber": "BHW853AU9H", "NameOfSubstance": "caryophyllene"}, {"RegistryNumber": "Y37615DVKC", "NameOfSubstance": "Bicuculline"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Anti-Anxiety Agents"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Anticonvulsants"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antidepressive Agents"}, {"QualifierName": [], "DescriptorName": "Arginine"}, {"QualifierName": [], "DescriptorName": "Behavior, Animal"}, {"QualifierName": ["metabolism"], "DescriptorName": "Benzodiazepines"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Bicuculline"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Flumazenil"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "GABA-A Receptor Antagonists"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Maze Learning"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Polycyclic Sesquiterpenes"}, {"QualifierName": ["metabolism"], "DescriptorName": "Receptors, GABA-A"}, {"QualifierName": ["chemically induced"], "DescriptorName": "Seizures"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2019", "Month": "12", "Day": "27"}, {"Year": "2020", "Month": "3", "Day": "31"}, {"Year": "2020", "Month": "4", "Day": "5"}, {"Year": "2020", "Month": "5", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "5", "Day": "11", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32386503", "10.2174/1874467213666200510004622", "CMP-EPUB-106485"]}}]}